"The Food and Drug Administration is poised as soon as Monday to restrict two monoclonal antibodies, saying the covid-19 treatments should not be employed in any states because they are ineffective against the dominant omicron variant, according to two senior administration health officials."

FDA ends for now use of two monoclonal antibodies, spurring a halt in federal shipments of the covid-19 treatments